These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17318456)

  • 1. Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Kirk J; Warner B; Lobb E; Gaff C; Tucker K
    J Genet Couns; 2007 Jun; 16(3):325-39. PubMed ID: 17318456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congress report of the seventh international meeting on psychosocial aspects of genetic testing for hereditary breast and/or ovarian cancer (HBOC) and hereditary non-polyposis colorectal cancer (HNPCC).
    Jordan J; Evans G; Evers-Kiebooms G; Julian-Reynier C; Kash K; Watson M
    Psychooncology; 2002; 11(6):536-9. PubMed ID: 12476435
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
    Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
    Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types.
    Wakefield CE; Kasparian NA; Meiser B; Homewood J; Kirk J; Tucker K
    Genet Test; 2007; 11(4):401-11. PubMed ID: 18294057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
    Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
    Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
    Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
    Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
    Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer.
    Nordin K; Lidén A; Hansson M; Rosenquist R; Berglund G
    J Med Genet; 2002 Sep; 39(9):689-94. PubMed ID: 12205115
    [No Abstract]   [Full Text] [Related]  

  • 10. Information processing in the context of genetic risk: implications for genetic-risk communication.
    Etchegary H; Perrier C
    J Genet Couns; 2007 Aug; 16(4):419-32. PubMed ID: 17473961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes toward colon cancer gene testing: factors predicting test uptake.
    Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a cancer genetic-specific measure of coping: the GRACE.
    Phelps C; Bennett P; Jones H; Hood K; Brain K; Murray A
    Psychooncology; 2010 Aug; 19(8):847-54. PubMed ID: 19823974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes.
    Balmaña J; Stoffel EM; Emmons KM; Garber JE; Syngal S
    J Med Genet; 2004 Apr; 41(4):e44. PubMed ID: 15060120
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploring the requirements for a decision aid on familial breast cancer in the UK context: a qualitative study with patients referred to a cancer genetics service.
    Iredale R; Rapport F; Sivell S; Jones W; Edwards A; Gray J; Elwyn G
    J Eval Clin Pract; 2008 Feb; 14(1):110-5. PubMed ID: 18211652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing.
    McAllister M
    Clin Genet; 2003 Sep; 64(3):179-89. PubMed ID: 12919131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
    Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.